Email Page Print Page

News & Media

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released via email or RSS.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011

2016 Archives

Dec 13, 2016
BDSI discontinues plan for further development resulting in an anticipated $16 million in operating plan savings in 2017 that extends cash runway
Dec 8, 2016
BELBUCA expected to be accretive to BDSI's 2017 net income and EPS
Nov 9, 2016
Six BUNAVAIL® Managed Care Agreements Secured Since July; Additional Access to BUNAVAIL Provides Potential for Strong First Half 2017 Growth
Oct 24, 2016
BUNAVAIL moved from non-formulary to preferred status
Oct 5, 2016
Timothy C. Tyson joins BDSI's board as an independent member with over 30 years of pharmaceutical experience
Sep 19, 2016
New contracts improve BUNAVAIL formulary status and give BUNAVAIL access to approximately 200,000 additional prescriptions for buprenorphine products for opioid dependence annually
Aug 9, 2016
BDSI targeting BUNAVAIL® profitability by end of 2017 following commercial restructuring, managed care wins and improved operating margins
Jul 11, 2016
Agreement provides BUNAVAIL with an opportunity to access a significant portion of more than 140,000 additional prescriptions annually